Loading compound...
Cyclophilin A inhibitor
Alisporivir is a protein-type molecule being researched for its ability to inhibit Cyclophilin A. While it has been studied for various conditions, it is primarily investigated for its potential use in treating Hepatitis C and COVID-19.
How it worksAlisporivir works by blocking a protein called Cyclophilin A.
Used for
Hepatitis C virus infectionChronic hepatitis C virus infectionLiver diseaseCOVID-19Chronic kidney disease
Conditions
Hepatitis C virus infectionChronic hepatitis C virus infectionLiver diseaseCOVID-19Chronic kidney disease
Class
Cyclophilin A inhibitor
How to take
Alisporivir is currently in clinical development phases and is not a standard approved treatment for these conditions according to the provided data.
Talk to your doctor
Questions to ask
- ·Is Alisporivir appropriate for my specific type of Hepatitis C?
- ·What are the potential risks of Cyclophilin A inhibitors?
- ·How does Alisporivir interact with my current liver medications?
Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.
